These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Collateral effects of L-dopa treatment in patients with parkinsonism]. Signorelli CD; D'Andrea F; De Divitiis E Sist Nerv; 1970; 22(2):109-14. PubMed ID: 5504548 [No Abstract] [Full Text] [Related]
6. Parkinson's disease treated with L-dopa. Three-year follow-up report. Mones RJ N Y State J Med; 1972 Nov; 72(22):2749-50. PubMed ID: 4510706 [No Abstract] [Full Text] [Related]
7. [Treatment of Parkinson's disease with L-dopa]. Guglielmi L; Vecchi L Clin Ter; 1970 May; 53(3):259-69. PubMed ID: 4917328 [No Abstract] [Full Text] [Related]
8. L-Dopa therapy of Parkinson's disease. (A review of the preliminary experience at West Virginia University). Gutmann L; Martin JD; Gutrecht JA W V Med J; 1970 Apr; 66(4):109-11. PubMed ID: 5264660 [No Abstract] [Full Text] [Related]
9. [Clinical study of L-dopa in Parkinson's disease]. Franken L; Noel G; Lhoas JP; Meyers C; Noel P; Ectors M Brux Med; 1972 Dec; 52(12):851-60. PubMed ID: 4575350 [No Abstract] [Full Text] [Related]
10. Treatment of parkinsonism with levo-dopa: results in 302 cases. Newkirk TA; Magee KR Mich Med; 1971 Sep; 70(22):805-11. PubMed ID: 5141211 [No Abstract] [Full Text] [Related]
11. Mental complications of L-dopa therapy in Parkinson's patients. Ginath Y; Lavy S; Abramsky O; Carmon A Isr Ann Psychiatr Relat Discip; 1971 Dec; 9(3):252-64. PubMed ID: 5291459 [No Abstract] [Full Text] [Related]
12. Preliminary observations on L-dopa in the treatment of Parkinson's disease. Jelsma F; Roth R; Ross P; Davis J J Ky Med Assoc; 1971 Apr; 69(4):265-9. PubMed ID: 5577419 [No Abstract] [Full Text] [Related]
13. [Treatment of Parkinsonic syndrome with levo-Dopa. Case reports]. Rosati G; Agnetti V; Mura F; Granieri E Minerva Med; 1974 May; 65(33):1811-23. PubMed ID: 4602058 [No Abstract] [Full Text] [Related]
14. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease. Andrews CJ; Somerville B Med J Aust; 1974 Mar; 1(12):429-32. PubMed ID: 4598384 [No Abstract] [Full Text] [Related]
15. L-dopa induced dyskinesias in 152 patients with Parkinson's disease. Mones RJ; Elizan TS; Siegel G Trans Am Neurol Assoc; 1970; 95():286-7. PubMed ID: 5514393 [No Abstract] [Full Text] [Related]
16. [Problems and therapy of L-DOPA-induced dyskinesias]. Völler GW; Deze J; Gundlach U; Muschard F Nervenarzt; 1972 Nov; 43(11):584-6. PubMed ID: 4564994 [No Abstract] [Full Text] [Related]
17. [Case reports of some mental disorders in parkinsonian patients treated with L-dopa]. Almici GM; Sbarbaro V Minerva Med; 1974 Feb; 65(8):398-401. PubMed ID: 4820722 [No Abstract] [Full Text] [Related]
18. [Treatment of Parkinson's disease with L-dopa and with a combination of L-dopa and dopa-decarboxylase inhibitor]. Agnoli A; Casacchia M; Reitano M; Ruggieri S; Barba C; Zamponi A Minerva Med; 1972 Dec; 63(89):4853-61. PubMed ID: 4566743 [No Abstract] [Full Text] [Related]
19. [Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor]. Guillard A Brux Med; 1972 Oct; 52(10):673-80. PubMed ID: 4656191 [No Abstract] [Full Text] [Related]
20. Side effects of L-dopa treatment. Greenburg J Pa Med; 1971 Apr; 74(4):55-6. PubMed ID: 5147645 [No Abstract] [Full Text] [Related] [Next] [New Search]